|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Impairment of intangible assets | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Financial income and other, net | |||||
| Income before taxes on income | |||||
| Tax benefit (taxes on income) | |||||
| Net Income | |||||
| Basic net income per share attributable to ordinary shareholders | |||||
| Basic weighted average ordinary shares | |||||
| Diluted net income per share attributable to ordinary shareholders | |||||
| Diluted weighted average ordinary shares | |||||
Loading...